Back
MFS Multimarket Income Trust Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
41
MMT
MFS Multimarket Income Trust
Last Price:
4.83
Seasonality Move:
-1.82%
Buy
57
RYTM
Rhythm Pharmaceuticals
Last Price:
53.08
Seasonality Move:
11.04%
Sell
41
MFS Multimarket Income Trust (MMT)
is a Sell
Is MFS Multimarket Income Trust a Buy, Sell or Hold?
- The current MFS Multimarket Income Trust [MMT] share price is $4.84. The Score for MMT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- MMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $49.52. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MMT Stock Price Chart
What is MFS Multimarket Income Trust's stock price today?
-
The MFS Multimarket Income Trust share price today is $4.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MMT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $49.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
MMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 63.32 | Buy |
| Chaikin Money Flow: | 64038 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.74 - 4.82) | Buy |
| Bollinger Bands (100): | (4.61 - 4.77) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.91 | Buy |
| Relative Strength Index (14 RSI): | 57.18 | Buy |
| Chaikin Money Flow: | -131805 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.52 - 49.1) | Buy |
| Bollinger Bands (100): | (39.32 - 48.12) | Buy |
MMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.81 | Buy |
| 20-day SMA: | 4.79 | Buy |
| 50-day SMA: | 4.75 | Buy |
| 200-day SMA: | 4.63 | Buy |
| 8-day EMA: | 4.81 | Buy |
| 20-day EMA: | 4.79 | Buy |
| 50-day EMA: | 4.75 | Buy |
| 200-day EMA: | 4.64 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.38 | Buy |
| 20-day SMA: | 47.68 | Buy |
| 50-day SMA: | 47.5 | Buy |
| 200-day SMA: | 43.19 | Buy |
| 8-day EMA: | 49.08 | Buy |
| 20-day EMA: | 48.09 | Buy |
| 50-day EMA: | 46.65 | Buy |
| 200-day EMA: | 41.27 | Buy |
MFS Multimarket Income Trust Earnings Growth & MMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.24 per share, a decrease this year of $1.32 per share, and an increase next year of $1.68 per share.
MFS Multimarket Income Trust Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||